CASTELLETTI, SEFORA
 Distribuzione geografica
Continente #
NA - Nord America 605
EU - Europa 345
AS - Asia 50
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.003
Nazione #
US - Stati Uniti d'America 603
IT - Italia 98
SE - Svezia 59
UA - Ucraina 56
IE - Irlanda 54
DE - Germania 26
DK - Danimarca 19
GB - Regno Unito 16
TR - Turchia 16
SG - Singapore 15
KR - Corea 11
FI - Finlandia 10
CN - Cina 5
NL - Olanda 3
AU - Australia 2
MX - Messico 2
AT - Austria 1
BE - Belgio 1
EU - Europa 1
HR - Croazia 1
ID - Indonesia 1
JP - Giappone 1
PK - Pakistan 1
RO - Romania 1
Totale 1.003
Città #
Chandler 119
Jacksonville 62
Dublin 54
Ashburn 50
Fairfield 41
Ann Arbor 20
Wilmington 20
Woodbridge 20
New York 19
Seattle 19
Boardman 18
Turin 18
Lawrence 17
Princeton 17
San Mateo 13
Des Moines 12
Redmond 12
Centro 11
Ancona 10
Houston 9
Cambridge 7
Napoli 7
Cagliari 6
Washington 5
Rome 4
San Diego 4
Beijing 3
London 3
Marche 3
Mountain View 3
Salerno 3
Amsterdam 2
Bologna 2
Cameri 2
Fiesole 2
Hounslow 2
Lucca 2
Monterrey 2
Nanjing 2
Norwalk 2
Pisa 2
San Severino Marche 2
Acton 1
Adelaide 1
Brussels 1
Chiaravalle 1
Chiswick 1
Cingoli 1
Esanatoglia 1
Helsinki 1
Islamabad 1
Kagoya 1
Kilburn 1
Kupang 1
Los Angeles 1
Mcallen 1
Melbourne 1
Milan 1
Montesilvano 1
Nürnberg 1
Palermo 1
Pesaro 1
Porto 1
San Benedetto Del Tronto 1
Suceava 1
Tolentino 1
Vienna 1
Zagreb 1
Totale 657
Nome #
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection 94
Spread of colistin resistance gene mcr-1 in Italy: characterization of the mcr-1.2 allelic variant in a colistin-resistant blood isolate of Escherichia coli 88
La resistenza agli antibiotici in Pseudomonas aeruginosa: studio molecolare ed epidemiologico in un nosocomio marchigiano 83
Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy 66
In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytes. 65
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. 64
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents. 62
Therapy with direct-acting antiviral agents in transplanted patients with HCV recurrence: a retrospective analysis 58
Efficacy and costs of Direct Acting Antivirals (DAAS) for the treatment of HCV Iinfection amnog HCV-monoinfected and HIV/HCV co-infected patients in real-life setting 57
In vitro activity of the lipopetide derivative (Pal-lys-lysNh2), alone and in combination with antifungal agents, against clinical isolates of dermatophytes 52
Direct acting antivirals (DAAs) for the treatment of HCV infection in HIV/HCV coinfected patients: a clinical experience. 52
null 47
null 41
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection. 40
Use of dalbavancin in skin, bone and joint infections: A real-life experience in an Italian center 38
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 37
Bloodstream infections in the COVID-19 era: results from an Italian multi-centre study 34
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 32
Antiretroviral therapy management and rationalisation of available resources 23
Totale 1.033
Categoria #
all - tutte 4.980
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.980


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 1 0 1
2019/2020105 2 0 10 1 16 0 12 1 16 27 6 14
2020/2021162 12 17 23 3 15 6 30 5 18 8 21 4
2021/2022137 4 31 1 8 3 2 14 10 12 5 14 33
2022/2023314 25 35 30 21 30 37 1 25 71 1 32 6
2023/2024186 29 13 17 28 38 41 3 14 3 0 0 0
Totale 1.033